Arabangsa, Asmera Jekerani J.

HRN: 29-21-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2026
CEFUROXIME 750MG (VIAL)
06/25/2026
07/01/2026
IV
460MG
Q8
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines